Third, previous research suggests the release of interleukins (IL-1β) in the immune system potentially facilitates the growth and invasion of tumors by stimulating the self-renewal of Cancer Stem Cells (CSC) and EMT [50]. The gene discussed is IL1B; the disease is cancer.